BlackRock Inc. Takes $15.77 Million Position in Lumexa Imaging Holdings, Inc. $LMRI

Key Points

• BlackRock acquired 1.4 million Lumexa Imaging shares during the second quarter, worth approximately $15.77 million and representing about 1.46% of the company.
• Lumexa reported quarterly EPS of $0.20, exceeding the $0.03 consensus estimate, on revenue of $264.16 million. Management issued fiscal 2026 EPS guidance of $0.71–$0.77.
• LMRI shares opened at $11.90, while analysts’ consensus rating is “Moderate Buy” with an average price target of $17.33; recent targets include $13 from Barclays and $16 from Deutsche Bank.

BlackRock Inc. bought a new position in shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,398,112 shares of the company's stock, valued at approximately $15,771,000. BlackRock Inc. owned approximately 1.46% of Lumexa Imaging at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Strs Ohio acquired a new position in shares of Lumexa Imaging during the 1st quarter worth about $38,000. PNC Financial Services Group Inc. acquired a new stake in shares of Lumexa Imaging during the 1st quarter worth about $63,000. State of Wyoming acquired a new stake in shares of Lumexa Imaging during the 1st quarter worth about $91,000. Barclays PLC purchased a new stake in Lumexa Imaging during the fourth quarter worth approximately $133,000. Finally, Sandia Investment Management LP purchased a new stake in Lumexa Imaging during the fourth quarter worth approximately $185,000.

Lumexa Imaging Stock Up 1.3%

Shares of NASDAQ LMRI opened at $11.90 on Friday. The business has a 50-day moving average price of $11.55 and a 200 day moving average price of $10.82. The stock has a market cap of $1.14 billion and a PE ratio of -24.29. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 1.40. Lumexa Imaging Holdings, Inc. has a 52-week low of $6.45 and a 52-week high of $19.45.

Lumexa Imaging (NASDAQ:LMRI - Get Free Report) last released its quarterly earnings results on Wednesday, August 12th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.03 by $0.17. The firm had revenue of $264.16 million for the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. Equities research analysts forecast that Lumexa Imaging Holdings, Inc. will post 0.25 earnings per share for the current year.

Analyst Upgrades and Downgrades

LMRI has been the topic of several recent analyst reports. Barclays increased their price target on shares of Lumexa Imaging from $9.00 to $13.00 and gave the company an "overweight" rating in a research note on Friday, August 28th. Weiss Ratings upgraded shares of Lumexa Imaging from a "sell (e)" rating to a "sell (d)" rating in a report on Thursday, June 25th. Deutsche Bank Aktiengesellschaft set a $16.00 target price on shares of Lumexa Imaging in a research report on Thursday, August 13th. Finally, Wall Street Zen upgraded shares of Lumexa Imaging from a "hold" rating to a "buy" rating in a research note on Sunday, August 16th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Lumexa Imaging has a consensus rating of "Moderate Buy" and a consensus price target of $17.33.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source